Andere Sprachen Generation Bio Co.

Aktien

A2P5NL

US37148K1007

GBIO

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
2,9 ^USD	-3,65 %		+3,57 %	+75,76 %

12.04.	Transcript : Generation Bio Co. - Special Call
07.03.	GENERATION BIO CO. : Needham & Co. gibt eine Kauf-Bewertung ab	ZM

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	22.04.
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference	02.04.
Generation Bio Co. Reports Earnings Results for the Full Year Ended December 31, 2023	06.03.
Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results	06.03.
Generation Bio Co. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06.03.
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	27.02.
Generation Bio to Present at the 2024 TD Cowen Health Care Conference	27.02.
Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference	03.01.
Generation Bio Co.(NasdaqGS:GBIO) dropped from NASDAQ Biotechnology Index	15.12.
Generation Bio Insider Bought Shares Worth $124,778, According to a Recent SEC Filing	05.12.
Generation Bio to Lay Off 40% of Staff in Bid to Extend Cash Runway Into H2 2027	29.11.
Generation Bio Co. Announces Termination of Executives, Effective on January 28, 2024	29.11.
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	29.11.
Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms	29.11.
Generation Bio Co. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09.11.
Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results	09.11.
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform	26.10.23
Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform	26.10.23
Generation Bio Co. Announces Demonstration of Highly Selective T Cell Transduction in Vivo with Cell-Targeted Lnp Platform	26.10.23
North American Morning Briefing : Yields Fall -2-	24.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Generation Bio Co.

Aktien

A2P5NL

US37148K1007

GBIO

Andere Sprachen

Filter